company background image
500259 logo

Lyka Labs BSE:500259 Stock Report

Last Price

₹110.85

Market Cap

₹3.7b

7D

0.8%

1Y

7.0%

Updated

24 Mar, 2024

Data

Company Financials

500259 Stock Overview

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India.

500259 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Lyka Labs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lyka Labs
Historical stock prices
Current Share Price₹110.85
52 Week High₹143.50
52 Week Low₹89.00
Beta1.19
1 Month Change-10.75%
3 Month Change-8.08%
1 Year Change7.05%
3 Year Change368.71%
5 Year Change352.45%
Change since IPO410.83%

Recent News & Updates

Recent updates

Shareholder Returns

500259IN PharmaceuticalsIN Market
7D0.8%1.1%1.0%
1Y7.0%65.8%47.0%

Return vs Industry: 500259 underperformed the Indian Pharmaceuticals industry which returned 65.8% over the past year.

Return vs Market: 500259 underperformed the Indian Market which returned 47% over the past year.

Price Volatility

Is 500259's price volatile compared to industry and market?
500259 volatility
500259 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 500259's share price has been volatile over the past 3 months.

Volatility Over Time: 500259's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976296Kunal Gandhihttps://www.lykalabs.com

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data.

Lyka Labs Limited Fundamentals Summary

How do Lyka Labs's earnings and revenue compare to its market cap?
500259 fundamental statistics
Market cap₹3.70b
Earnings (TTM)-₹36.68m
Revenue (TTM)₹1.02b

3.6x

P/S Ratio

-100.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500259 income statement (TTM)
Revenue₹1.02b
Cost of Revenue₹425.24m
Gross Profit₹594.86m
Other Expenses₹631.54m
Earnings-₹36.68m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.11
Gross Margin58.31%
Net Profit Margin-3.60%
Debt/Equity Ratio79.2%

How did 500259 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.